Expression of Elf1 and survivin in nonsmall cell lung cancer and their relationship to intratumoral microvessel density

Chinese Journal of Cancer

Volumn 29, Issue 4, 2010, Pages 396-402

  Yang, Dongxia ^a   Li, Naie ^a   Ma, Yun ^a   Han, Yanchun ^a   Shi, Yan ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Elf 1; IMVD; Lung neoplasm; Surviving

Indexed keywords

ENDOGLIN; SURVIVIN; TRANSCRIPTION FACTOR ELF 1; VASCULOTROPIN; BIRC5 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; ELF1 PROTEIN, HUMAN; ENG PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; LEUKOCYTE ANTIGEN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER STAGING; CELL CYCLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL RATE; SURVIVAL TIME; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION; CELL DIFFERENTIATION; LUNG TUMOR; METABOLISM; MICROVASCULATURE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; RECEPTORS, CELL SURFACE; SURVIVAL RATE; TRANSCRIPTION FACTORS;

EID: 79955843878     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10547     Document Type: Article

References (18)

1. Bredemeier-Em st I, Nordheim A, Janknecht R.Transcriptional activity and constitutive nuclear localizatioon of the Ets protein Elf-1 [J].FEBS Lett, 1997-408(1):47-51.
2. Yang DX, Han YC, Liu LY, et al. Expression and significance of Elf-1 and vascular endothelial growth factor in non-sm all cell lung cancer [J]. Chin J Cancer, 2009,28(7):762-767. [in Chinese]
3. Yang J, Liu FX, Yan XC, et al. Clinical significance of Survivin expression in colorectal cancer and its relationship with cell apoptosis and angiogenesis [J]. Chin J Cancer, 2005,24(1):116-120. [in Chinese]
4. Akagi K, Ikeda Y, Sumiyoshi Y,et al. Estimation of angiogenesis with anti- CD105 immunostaning in the process of colorectal cancer development [J]. Surgery, 2002,131:s109-s113.
5. Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, Survivin, correlated with tumor cell apoptosis and P53 accumulation in gastric carcinomas [J]. Cancer Res, 1998, 58 (9):1808- 1812.
6. Weidner N. Intratumor microvessel density as a prognostic factor in cancer [J].Am J Pathal,1995, 147(1):9-19.
7. Costa C, Soares R, Schmitt F. Angiogenesis: now and then [J]. APMIS, 2004, 112(7-8):402-412.
8. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis [J]. J Clin Oncol, 2005, 23 (5):1011-1027.
9. Harlozinska A. Progress in molecular mechanisms of tumor metastasis and angiogenesis [J]. Anticancer Res, 2005,25(5):3327-3333.
10. Fox CH, Whalen GF, SandersMM, et al. Angiogenesis in normal tissue adjacent to colon cancer[J]. J Surg Oncol, 1998, 69(4): 230-234.
11. Schimming R, Reusch P, Kuschnierz J, et al. Angiogenic factors in squamous cell carcinoma of the oral cavity: do they have prognostic relevance [J]. J raniomaxillofac Surg, 2004, 32(3): 176-181.
12. Huang X, Brown C, Ni W, et al. Critical role for the Ets transcription factor ELF-1 in the development oftumor angiogenesis [J]. Blood, 2006,107(8):3153-3160.
13. Konno S, Iizuka M, Yukawa M, et al. Altered expression of angiogenic factors in the VEGF-Et s-1 cascades in inflammatory bowel disease [J]. J Gastroenterol, 2004,39(10):931-939.
14. Khatun S, Fujimoto J, Toyoki H, et al. Clinical implications of expression of ELF-1 in relation to angiogenesis in ovarian cancers [J]. Cancer Sci, 2003,94(9):769-773.
15. Wang ZN, Xu HM, Jiang L, et al. Expression of Survivin in primary and metastatic gastric cancer cells obtained by lasercap turem icrodissection [J]. World J Gastroenterol, 2004, 10 (21): 3094-3098.
16. Lee GH, Joo YE, Koh YS, et al. Expression of Survivin in gastric cancer and its relationship with tumor angiogenesis [J]. Eur J Gastroenterol Hepatol, 2006, 18 (9): 957-963.
17. Mesri M, Morales-Ruiz M, Ackermann EJ, et al. Suppression of vascular endothelial growth factor-m ediated endothelial cell protection by surviving targeting[J].Am J Pathol, 2001,158(5):1757-1765.
18. Uren AG, Wong L, Pakusch M, et al. Survivin and the inner centromere protein INCENP show similar cell-cy cle localization and gene knockout phenotype[J]. Curr Biol, 2000,10(21):1319-1328.